Diltiazem
Diltiazem is a pharmaceutical drug with 46 clinical trials. Currently 3 active trials ongoing. Historical success rate of 88.6%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
22
Early Stage
5
Mid Stage
17
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.1%
31 of 36 finished
13.9%
5 ended early
3
trials recruiting
46
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
Diltiazem in Jervell and Lange-Nielsen Syndrome
Adenosine vs Diltiazem for Treatment of SVT in the ED
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
Clinical Trials (46)
A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
Diltiazem in Jervell and Lange-Nielsen Syndrome
Adenosine vs Diltiazem for Treatment of SVT in the ED
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure
A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)
A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003)
A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection.
A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants
Heart Rate Controller in Computed Tomography Coronary Angiography
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
Rate Control in Atrial Fibrillation II
A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS-986209 in Healthy Participants
Efficacy of Oral Verapamil and Oral Diltiazim on Reduction of Intraoperative Bleeding During Endoscopic Sinus Surgery Under General Anesthesia
A Study of LY2623091 in Healthy Participants
The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 46